JPMorgan Chase & Co. bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 721,787 shares of the company’s stock, valued at approximately $58,638,000. JPMorgan Chase & Co. owned about 0.16% of GE HealthCare Technologies at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Meitav Investment House Ltd. bought a new position in GE HealthCare Technologies in the 2nd quarter worth about $113,000. Center for Financial Planning Inc. bought a new position in GE HealthCare Technologies in the 2nd quarter worth about $26,000. Aspire Private Capital LLC bought a new position in GE HealthCare Technologies in the 2nd quarter worth about $26,000. Larson Financial Group LLC bought a new position in GE HealthCare Technologies in the 2nd quarter worth about $27,000. Finally, Sanctuary Wealth Management L.L.C. bought a new position in GE HealthCare Technologies in the 2nd quarter worth about $28,000. Institutional investors own 79.18% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have recently weighed in on GEHC shares. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $86.00 to $66.00 in a research note on Monday, November 27th. Jefferies Financial Group started coverage on shares of GE HealthCare Technologies in a research note on Thursday. They issued a “hold” rating and a $80.00 price target for the company. Wells Fargo & Company started coverage on shares of GE HealthCare Technologies in a research note on Wednesday, August 16th. They issued an “overweight” rating and a $90.00 price target for the company. Argus started coverage on shares of GE HealthCare Technologies in a research note on Friday, August 25th. They issued a “buy” rating and a $80.00 price target for the company. Finally, Citigroup started coverage on shares of GE HealthCare Technologies in a research note on Tuesday, September 19th. They issued a “buy” rating and a $82.00 price target for the company. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $85.60.
View Our Latest Stock Analysis on GEHC
GE HealthCare Technologies Trading Up 1.4 %
Shares of NASDAQ GEHC opened at $69.41 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $53.00 and a 12 month high of $87.83. The company has a market cap of $31.60 billion and a price-to-earnings ratio of 20.66. The company has a quick ratio of 0.97, a current ratio of 1.25 and a debt-to-equity ratio of 1.44. The business has a fifty day simple moving average of $68.46 and a 200-day simple moving average of $72.93.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its earnings results on Tuesday, October 31st. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.89 by $0.10. The business had revenue of $4.82 billion during the quarter, compared to the consensus estimate of $4.80 billion. GE HealthCare Technologies had a return on equity of 24.46% and a net margin of 8.91%. GE HealthCare Technologies’s revenue was up 5.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.87 earnings per share. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 3.81 EPS for the current year.
GE HealthCare Technologies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Friday, October 20th were paid a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.17%. The ex-dividend date was Thursday, October 19th. GE HealthCare Technologies’s dividend payout ratio is currently 3.57%.
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.
Featured Articles
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and GE HealthCare Technologies wasn’t on the list.
While GE HealthCare Technologies currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Source: marketbeat.com
